Astrazeneca PLC Sponsored ADR (AZN)

50.16
0.91 1.78
NASDAQ
Prev Close 51.07
Open 50.92
Day Low/High 49.79 / 51.20
52 Wk Low/High 36.15 / 64.94
Volume 4.75M
Exchange NASDAQ
P/E Ratio 49.58
Div & Yield N.A. (N.A)

Latest News

Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade

Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade

Covid itself, and therapeutics or vaccines associated with taking on the SARS-CoV-2 coronavirus, is under a public microscope.

J&J's Pause, Nasdaq Thumbs Up, Amazon Prime Day, Apple Hi, Speed, Veeva Breakout

J&J's Pause, Nasdaq Thumbs Up, Amazon Prime Day, Apple Hi, Speed, Veeva Breakout

Now, that we have confirmation from the Nasdaq Composite, I think we can say equity markets are indeed back in what I would consider an uptrend.

Trump's Health and the Market, Charts That Matter, Nvidia News, URI Breaks Out

Trump's Health and the Market, Charts That Matter, Nvidia News, URI Breaks Out

Even more important than fiscal support moving forward would be the concept of Covid-19 very soon being effectively treatable for the public.

Certainty of Uncertainty, Lines in the Sand, Election Fears, Fed Alone, Twitter

Certainty of Uncertainty, Lines in the Sand, Election Fears, Fed Alone, Twitter

The result has been a technical breakdown in risk-asset pricing -- and the main culprit is without a doubt, the inability of Congress to compromise.

Veeva and RedHill: 2 Stocks to Consider as They Team Up to Battle Covid-19

Veeva and RedHill: 2 Stocks to Consider as They Team Up to Battle Covid-19

RedHill Biopharma has adopted 'Veeva Vault CDMS', Veeva's modern cloud platform.

Stock-Specific Ideas for the Post-Fed Era of Investing

Stock-Specific Ideas for the Post-Fed Era of Investing

Make sure that your portfolio is composed of sane assets for the balance of this crazy year.

Is It Safe Now? Wall Street Bets on Science, Joy in Metville, Citi's Selloff

Is It Safe Now? Wall Street Bets on Science, Joy in Metville, Citi's Selloff

Electoral risk remains the monster under the bed, and it only grows as our legislators intentionally choose the blame game over honest cooperation.

Jim Cramer: These Stocks Show the Market's Betting on a Vaccine

Jim Cramer: These Stocks Show the Market's Betting on a Vaccine

The prices of hotels and even beaten up retailers say that many believe a vaccine is on the way -- here's how I would get positioned.

How About That Merck and Seattle Genetics Deal?

How About That Merck and Seattle Genetics Deal?

I am long Merck, not Seattle Genetics, though the one to own now is obviously SGEN.

Challenging Markets, Nvidia Acquires Arm, Oracle Wins TikTok, Vaccine Update

Challenging Markets, Nvidia Acquires Arm, Oracle Wins TikTok, Vaccine Update

Also, several scheduled events this week, election risk, earnings to watch.

This Biotech Appears to Have the Right Formula for Investors

This Biotech Appears to Have the Right Formula for Investors

After reviewing the rally, let's zero in on one biotech name, Genprex, and where it appears to be going.

My Vaccine Bet Remains on Pfizer for a Disease I Don't Wish on Anyone

My Vaccine Bet Remains on Pfizer for a Disease I Don't Wish on Anyone

This writer is rooting for the success of all efforts to halt the spread of the virus as he struggles with the aftereffects of the disease.

Last Night I Took Short-Term Rental Longs in SPY, QQQ

* On counter punching * And being opportunistic, flexible and unemotional As you all recognize I work off an investment thesis, the foundation of which typically is the relationship of a stock, a sector or an Index to my calculation of "fair market ...

No Rotation, No Panic, Nasdaq's Crucial Line, Tesla's Truly Bad Day, Apple Stung

No Rotation, No Panic, Nasdaq's Crucial Line, Tesla's Truly Bad Day, Apple Stung

We must see equity markets, the Nasdaq Composite and Nasdaq 100 in particular, fight back this week to keep on believing in this market.

That Stings: AZN Vaccine Trial Reportedly on Hold

"Just one more thing." - Lt. Columbo Statnews.com is reporting that the phase 3 study for AstraZeneca's Covid-19 vaccine is put on hold. 

Moderna and AstraZeneca Could Use a Shot in the Arm

Moderna and AstraZeneca Could Use a Shot in the Arm

An effective Covid-19 will be a game-changer, but charts say the bottom-line impact may not be as significant as previously believed.

Waves of Buying, Above-Average Indices, Vaccine Mania: Market Recon

Waves of Buying, Above-Average Indices, Vaccine Mania: Market Recon

Plus, reading tea leaves in the recent action in Apple and Salesforce.com.

A Healthy Dose of Vaccine and Pharmaceutical Plays

A Healthy Dose of Vaccine and Pharmaceutical Plays

6 favorite stocks and ETFs in the biotech and pharmaceutical sector, including a diversified basket of Covid-19 vaccine names.

Apple Still King, Dow Shell Game, More Market Faith, Renewed China Talks?

Apple Still King, Dow Shell Game, More Market Faith, Renewed China Talks?

Monday's market action was in no way similar to that recent disparity between the 'haves' and 'have nots.'

The Week Ahead, Markets Haven't Been Wrong, Closer to a Vaccine? Watching J&J

The Week Ahead, Markets Haven't Been Wrong, Closer to a Vaccine? Watching J&J

The equity market recovery is just as sloppy in performance as the economy itself.

Parabolic AMD, Agreeing to Agree, Disney's GAAP Earnings Gap: Market Recon

Parabolic AMD, Agreeing to Agree, Disney's GAAP Earnings Gap: Market Recon

It is going to take successful vaccines and therapies and much lower unemployment to revive most of Walt Disney Co.'s businesses.

Across the Pond: 5 ETFs for European Equity Exposure

Across the Pond: 5 ETFs for European Equity Exposure

European markets have been slumping for years, but the time for those countries to shine again may finally be around the corner.

Ozzy and I Don't Know, Hare-Raising Tale, Enter the Dog Days: Market Recon

Ozzy and I Don't Know, Hare-Raising Tale, Enter the Dog Days: Market Recon

Plus, Russia could provide a real-time clinical trial of a coronavirus vaccine.

Big Tech's Big Night, Eyeing Amazon, My Kodak Moment, Powell's Blunt Assessment

Big Tech's Big Night, Eyeing Amazon, My Kodak Moment, Powell's Blunt Assessment

The Fed has done a lot, and is willing to do even more, but for now, is watching Congress. The fiscal side is where the next shoe falls.

Jim Cramer: I'm Sick of Hearing All This Nonsense About the Fed

Jim Cramer: I'm Sick of Hearing All This Nonsense About the Fed

Let me disabuse you of some of the biggest canards that people routinely spout involving the Fed and stocks.

Jim Cramer: Handicapping the Major Covid-19 Vaccine Makers

Jim Cramer: Handicapping the Major Covid-19 Vaccine Makers

Our fate is in the hands of a few dozen companies with a dizzying array of clinical trials, and whoever gets there first is gonna make a fortune.

Jim Cramer: We Have Now Developed a Truly Roulette Market

Jim Cramer: We Have Now Developed a Truly Roulette Market

You can bet on black, which is instant vaccine, or you can bet on red, which is the shutdown non-economy. Both have variants.

AstraZeneca Could Continue to Higher Highs

AstraZeneca Could Continue to Higher Highs

Oxford University, along with Britain's AstraZeneca, published promising data from an early stage trial of a key coronavirus vaccine study Monday in London.